Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells

International Journal of Oral and Maxillofacial Surgery

Volumn 36, Issue 8, 2007, Pages 739-744

  Xu, J ^a   Huang, H ^a   Pan, C ^a   Zhang, B ^a   Liu, X ^a   Zhang, L ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

apoptosis; nicotine; oral cancer; survivin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CISPLATIN; NICOTINE; PROTEIN KINASE B; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; DRUG INTERACTIONS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NICOTINE; NICOTINIC AGONISTS; ONCOGENE PROTEIN V-AKT; RNA, SMALL INTERFERING;

EID: 34447627178     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2007.05.016     Document Type: Article

References (29)

1. Arredondo J., Chernyavsky A.I., and Grando S.A. Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells. Cancer Biol Ther 5 (2006) 511-517
2. Arredondo J., Chernyavsky A.I., Jolkovsky D.L., Pinkerton K.E., and Grando S.A. Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J 20 (2006) 2093-2101
3. Carvalho A., Carmena M., Sambade C., Earnshaw W.C., and Wheatley S.P. Survivin is required for stable checkpoint activation in Taxol-treated HeLa cells. J Cell Sci 116 (2003) 2987-2998
4. Conti-Fine B.M., Navaneetham D., Lei S., and Maus A.D. Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?. Eur J Pharmacol 393 (2000) 279-294
5. Dasgupta P., Kinkade R., Joshi B., Decook C., Haura E., and Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 103 (2006) 6332-6337
6. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
7. Gardai S.J., Hildeman D.A., Frankel S.K., Whitlock B.B., Frasch S.C., Borregaard N., Marrack P., Bratton D.L., and Henson P.M. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 279 (2004) 21085-21095
8. Jatin P.S. Cancer of the Head and Neck (American Cancer Society Atlas of Oncology) (2001), Bc Decker Inc., London 1-4
9. Jin Z., Gao F., Flagg T., and Deng X. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J Biol Chem 279 (2004) 40209-40219
10. Kim S., Kang J., Qiao J., Thomas R.P., Evers B.M., and Chung D.H. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas. J Pediatr Surg 39 (2004) 516-521
11. Lee H.J., Guo H.Y., Lee S.K., Jeon B.H., Jun C.D., Lee S.K., Park M.H., and Kim E.C. Effects of nicotine on proliferation, cell cycle, and differentiation in immortalized and malignant oral keratinocytes. J Oral Pathol Med 34 (2005) 436-443
12. Lo Muzio L., Farina A., Rubini C., Pezzetti F., Stabellini G., Laino G., Santarelli A., Pannone G., Bufo P., de Lillo A., and Carinci F. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett 225 (2005) 27-33
13. Minna J.D. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest 111 (2003) 31-33
14. Miyashita H., Nitta Y., Mori S., Kanzaki A., Nakayama K., Terada K., Sugiyama T., Kawamura H., Sato A., Morikawa H., Motegi K., and Takebayashi Y. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin. Oral Oncol 39 (2003) 157-162
15. Mousa S., and Mousa S.A. Cellular and molecular mechanisms of nicotine's pro-angiogenesis activity and its potential impact on cancer. J Cell Biochem 97 (2006) 1370-1378
16. Ohashi H., Takagi H., Oh H., Suzuma K., Suzuma I., Miyamoto N., Uemura A., Watanabe D., Murakami T., Sugaya T., Fukamizu A., and Honda Y. Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity. Circ Res 94 (2004) 785-793
17. Onoda N., Nehmi A., Weiner D., Mujumdar S., Christen R., and Los G. Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents. Head Neck 23 (2001) 860-870
18. Paduano F., Villa R., Pennati M., Folini M., Binda M., Daidone M.G., and Zaffaroni N. Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells. Mol Cancer Ther 5 (2006) 179-186
19. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
20. Singh N., Khanna N., Sharma H., Kundu S., and Azmi S. Insights into the molecular mechanism of apoptosis induced by TNF-alpha in mouse epidermal JB6-erived RT-101 cells. Biochem Biophys Res Commun 295 (2002) 24-30
21. Tamatani T., Azuma M., Ashida Y., Motegi K., Takashima R., Harada K., Kawaguchi S., and Sato M. Enhanced radiosensitization and chemosensitization in NF-kappaB-suppressed human oral cancer cells via the inhibition of gamma-irradiation- and 5-FU-induced production of IL-6 and IL-8. Int J Cancer 108 (2004) 912-921
22. Tamm I., Wang Y., Sausville E., Scudiero D.A., Vigna N., Oltersdorf T., and Reed J.C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58 (1998) 5315-5320
23. Tanaka C., Uzawa K., Shibahara T., Yokoe H., Noma H., and Tanzawa H. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82 (2003) 607-611
24. Tsurutani J., Castillo S.S., Brognard J., Granville C.A., Zhang C., Gills J.J., Sayyah J., and Dennis P.A. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis 26 (2005) 1182-1195
25. Warnakulasuriya S., Sutherland G., and Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol 41 (2005) 244-260
26. Wright S.C., Zhong J., Zheng H., and Larrick J.W. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J 7 (1993) 1045-1051
27. Wu X.H., Wang H.F., Liu Y.F., Lu X.Y., Wang J.J., and Li K. Histone adduction with nicotine: a bio-AMS study. Radiocarbon 39 (1997) 293-297
28. Xin M., and Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 280 (2005) 10781-10789
29. Zaffaroni N., Pennati M., and Daidone M.G. Survivin as a target for new anticancer interventions. J Cell Mol Med 9 (2005) 360-372